Visceral leishmaniasis in the hills of western Nepal: A transmission assessment.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2024
Historique:
received: 22 07 2023
accepted: 12 02 2024
medline: 17 4 2024
pubmed: 17 4 2024
entrez: 17 4 2024
Statut: epublish

Résumé

In Nepal, visceral leishmaniasis (VL) has been targeted for elimination as a public health problem by 2026. Recently, increasing numbers of VL cases have been reported from districts of doubtful endemicity including hills and mountains, threatening the ongoing VL elimination program in Nepal. We conducted a multi-disciplinary, descriptive cross-sectional survey to assess the local transmission of Leishmania donovani in seven such districts situated at altitudes of up to 1,764 meters in western Nepal from March to December 2019. House-to-house surveys were performed for socio-demographic data and data on past and current VL cases. Venous blood was collected from all consenting individuals aged ≥2 years and tested with the rK39 RDT. Blood samples were also tested with direct agglutination test, and a titer of ≥1:1600 was taken as a marker of infection. A Leishmania donovani species-specific PCR (SSU-rDNA) was performed for parasite species confirmation. We also captured sand flies using CDC light traps and mouth aspirators. The house-to-house surveys documented 28 past and six new VL cases of which 82% (28/34) were without travel exposure. Overall, 4.1% (54/1320) of healthy participants tested positive for L. donovani on at least one serological or molecular test. Among asymptomatic individuals, 17% (9/54) were household contacts of past VL cases, compared to 0.5% (6/1266) among non-infected individuals. Phlebotomus argentipes, the vector of L. donovani, was found in all districts except in Bajura. L. donovani was confirmed in two asymptomatic individuals and one pool of sand flies of Phlebotomus (Adlerius) sp. We found epidemiological and entomological evidence for local transmission of L. donovani in areas previously considered as non-endemic for VL. The national VL elimination program should revise the endemicity status of these districts and extend surveillance and control activities to curb further transmission of the disease.

Identifiants

pubmed: 38630746
doi: 10.1371/journal.pone.0289578
pii: PONE-D-23-20271
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0289578

Informations de copyright

Copyright: © 2024 Uranw et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Surendra Uranw (S)

Department of Internal Medicine, B.P. Koirala Institute of Health Sciences, Dharan, Nepal.

Narayan Raj Bhattarai (NR)

Department of Microbiology, B.P. Koirala Institute of Health Sciences, Dharan, Nepal.

Kristien Cloots (K)

Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.

Lalita Roy (L)

Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
Tropical & Infectious Diseases Center, B.P. Koirala Institute of Health Sciences, Dharan, Nepal.

Keshav Rai (K)

Department of Microbiology, B.P. Koirala Institute of Health Sciences, Dharan, Nepal.

Usha Kiran (U)

World Health Organization, Country Office for Nepal, Kathmandu, Nepal.

Uttam Raj Pyakurel (UR)

Epidemiology and Disease Control Division, Department of Health Services, Government of Nepal, Kathmandu, Nepal.

Bibek Kumar Lal (BK)

Epidemiology and Disease Control Division, Department of Health Services, Government of Nepal, Kathmandu, Nepal.

Sakib Burza (S)

Faculty of Infectious Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.

Suman Rijal (S)

Drugs for Neglected Diseases Initiative, India Office, New Delhi, India.

Prahlad Karki (P)

Department of Internal Medicine, B.P. Koirala Institute of Health Sciences, Dharan, Nepal.

Basudha Khanal (B)

Department of Microbiology, B.P. Koirala Institute of Health Sciences, Dharan, Nepal.

Epco Hasker (E)

Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.

Classifications MeSH